Displaying drugs 14426 - 14450 of 14853 in total
2-chloro-5-nitro-N-phenylbenzamide
Experimental
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
Experimental
2,6-dibromo-4-phenoxyphenol
Experimental
N-phenyl-1H-pyrazole-3-carboxamide
Experimental
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
Experimental
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole targets the protein genome polyprotein.
Experimental
2-(4-METHOXYPHENYL)ACETAMIDE
Experimental
4-(2-AMINOETHYL)BENZENESULFONAMIDE
Experimental
Ponazuril
Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
Vet approved
Chlorproguanil
Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
Investigational
Clofoctol
Experimental
Tolpropamine
Experimental
Suloctidil
Experimental
Displaying drugs 14426 - 14450 of 14853 in total